QIAGEN and Sentieon Partner to Advance Precision Medicine With Highly Efficient Variant-Calling Software

QIAGEN N.V. and Sentieon, Inc. today announced a collaboration to advance precision medicine by delivering Sentieon’s award-winning software for calling variants as part of QIAGEN’s industry-leading bioinformatics portfolio, supporting thousands of next-generation sequencing (NGS) labs.

Please to read the entire article.